510(k) Report

510(k) · Cleared

Cleared

Homocysteine Microtiter Plate Assay

K032012510(k) TraditionalCleared Sep 3, 200365-day reviewClass II21 CFR 862.1377

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diazyme Laboratories · LPS Urinary Homocystine (Nonquantitative) Test System

Cleared on Sep 3, 2003 as substantially equivalent to K980907 (Axis Biochemicals, Asa, 1998) after a 65-day review. Its family tree reaches back 1 generation to 1998.

Decided
Sep 3, 2003
Review
65 days
Class
Class II
Product code
LPS
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K980907 (1998). No later device cites it as a predicate yet.

K980907 · Axis Homocysteine Enzyme Immunoassay · Axis Biochemicals, Asa · 199819961998200020022004
  1. Root · 1 generation backK980907 Axis Homocysteine Enzyme ImmunoassayAxis Biochemicals, Asa · 1998
  2. This deviceK032012 Homocysteine Microtiter Plate AssayDiazyme Laboratories · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K980907Axis Homocysteine Enzyme ImmunoassayAxis Biochemicals, Asa1998—
0 (this device)K032012Homocysteine Microtiter Plate AssayDiazyme Laboratories2003—
FIG. 1 — Lineage of K032012, 1998–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980907Axis Homocysteine Enzyme Immunoassay
Summary page 1
…marketed device to which we are claiming equivalence [807.92(a)(3)]: Axis Homocysteine EIA, manufactured by Axis Biochemicals, AS. The clearance number is K980907. Description of the device: Homocysteine Microplate HPB Assay is an EIA-like assay for the determination of tHcy…
Axis Biochemicals, Asa1998—

Also cleared against K980907: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K980907.

How does its category compare?

All LPS devices

LPS Urinary Homocystine (Nonquantitative) Test System: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LPS

1in 2013

2007: 22008: 22009: 12012: 42013: 1
2007high 4 (2012) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPS

141in 2012

2012: 141 days median
2007high 141 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPS

1in 2024

2007: 12011: 12012: 12013: 12018: 12019: 42024: 1
2007high 4 (2019) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPS

1in 2024

2014: 12015: 22016: 12017: 82021: 12024: 1
2007high 8 (2017) · low 0 (2007)2025

MAUDE reports naming product code LPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—10
20082—00
20091—00
20100—00
20110—10
2012414110
20131—10
20140—01
20150—02
20160—01
20170—08
20180—10
20190—40
20200—00
20210—01
20220—00
20230—00
20240—11
20250—00
20260—0—

What is it indicated for?

The Homocysteine Microtiter Plate Assay is intended for the quantitative determination of total L-homocysteine in human serum or plasma.

The device can assist in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia and homocystinuria.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032012: Homocysteine Microtiter Plate Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032012

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026